Compounds > nalmefene

nalmefene and Liver Dysfunction

nalmefene has been researched along with Liver Dysfunction in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dixon, R; Frye, RF; Matzke, GR; Rabinovitz, M; Schade, R1

Other Studies

2 other study(ies) available for nalmefene and Liver Dysfunction

ArticleYear
Nalmefene--a long-acting injectable opioid antagonist.
    The Medical letter on drugs and therapeutics, 1995, Oct-27, Volume: 37, Issue:960

    Topics: Clinical Trials as Topic; Costs and Cost Analysis; Dose-Response Relationship, Drug; Drug Overdose; Humans; Injections, Intravenous; Kidney Failure, Chronic; Liver Diseases; Naltrexone; Narcotic Antagonists; Postoperative Care; Respiratory Insufficiency

1995
Effects of liver disease on the disposition of the opioid antagonist nalmefene.
    Clinical pharmacology and therapeutics, 1997, Volume: 61, Issue:1

    Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antipyrine; Case-Control Studies; Female; Galactose; Glucuronates; Humans; Injections, Intravenous; Liver Diseases; Male; Matched-Pair Analysis; Middle Aged; Naltrexone; Narcotic Antagonists; Severity of Illness Index

1997